Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 329-337

  Morel, Sandrine ^a   Braunersreuther, Vincent ^a   Chanson, Marc ^a   Bouis, Diane ^b   Rochemont, Viviane ^a   Foglia, Bernard ^a   Pelli, Graziano ^a   Sutter, Esther ^a   Pinsky, David J ^b   MacH, François ^a   Kwak, Brenda R ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiac ischaemia reperfusion injury; Cx40; Gap junction; Neutrophil recruitment

Indexed keywords

CHOLESTEROL; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; EOSIN; HEMATOXYLIN; METHOTREXATE; 5' NUCLEOTIDASE; GAP JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL INTERACTION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EX VIVO STUDY; HEART INFARCTION SIZE; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPERFUSION INJURY; SINGLE DRUG DOSE; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; GAP JUNCTION; ISCHEMIA; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

5'-NUCLEOTIDASE; ANIMALS; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GAP JUNCTIONS; ISCHEMIA; MICE; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION;

EID: 84899096297     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu063     Document Type: Article

References (46)

1. Yellon DM Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135
2. Kalogeris T Baines CP Krenz M Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012;298:229-317
3. Frohlich GM Meier P White SK Yellon DM Hausenloy DJ. Myocardial reperfusion injury: Looking beyond primary PCI. Eur Heart J 2013;34:1714-1722
4. Hausenloy DJ Erik Botker H Condorelli G Ferdinandy P Garcia-Dorado D Heusch G Lecour S van Laake LW Madonna R Ruiz-Meana M Schulz R Sluijter JP Yellon DM Ovize M. Translating cardioprotection for patient benefit: Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2013;98:7-27
5. Taqueti VR Mitchell RN Lichtman AH. Protecting the pump: Controlling myocardial inflammatory responses. Annu Rev Physiol 2006;68:67-95
6. Timmers L Pasterkamp G de Hoog VC Arslan F Appelman Y de Kleijn DP. The innate immune response in reperfused myocardium. Cardiovasc Res 2012;94:276-283
7. Steffens S Montecucco F Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb Haemost 2009;102:240-247
8. Moens AL Claeys MJ Timmermans JP Vrints CJ. Myocardial ischemia/reperfusioninjury a clinical view on a complex pathophysiological process. Int J Cardiol 2005;100: 179-190
9. Kolaczkowska E Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159-175
10. Weber C Fraemohs L Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007;7:467-477
11. Bradfield PF Nourshargh S Aurrand-Lions M Imhof BA. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 2007;27: 2104-2112
12. Chadjichristos CE Scheckenbach KE van Veen TA Richani Sarieddine MZ de Wit C Yang Z Roth I Bacchetta M Viswambharan H Foglia B Dudez T van Kempen MJ Coenjaerts FE Miquerol L Deutsch U Jongsma HJ Chanson M Kwak BR. Endothelialspecific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation 2010;121:123-131
13. Gros DB Jongsma HJ. Connexins in mammalian heart function. Bioessays 1996;18: 719-730
14. Hou CJ Tsai CH Yeh HI. Endothelial connexins are down-regulated by atherogenic factors. Front Biosci 2008;13:3549-3557
15. Tyml K. Role of connexins in microvascular dysfunction During inflammation. Can J Physiol Pharmacol 2011;89:1-12
16. Wong CW Christen T Roth I Chadjichristos CE Derouette JP Foglia BF Chanson M Goodenough DA Kwak BR. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006;12:950-954
17. Hasegawa T Bouis D Liao H Visovatti SH Pinsky DJ. Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res 2008;103:1410-1421
18. Milano G Morel S Bonny C Samaja M von Segesser LK Nicod P Vassalli G. A peptide inhibitor of c-Jun NH2-Terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am J Physiol Heart Circ Physiol 2007;292:H1828-H1835.
19. Braunersreuther V Pellieux C Pelli G Burger F Steffens S Montessuit C Weber C Proudfoot A MachF Arnaud C.Chemokine CCL5/RANTESinhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol 2010;48:789-798
20. Morel S Frias MA Rosker C JamesRW Rohr S Kwak BR. The natural cardioprotective particle HDL modulates connexin43 gap junction channels. Cardiovasc Res 2012;93: 41-49
21. de Wit C Roos F Bolz SS Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 2003;13:169-177
22. Simon AM Goodenough DA Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998;8:295-298
23. Zhang SH Reddick RL Piedrahita JA Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471
24. Yan X Anzai A Katsumata Y Matsuhashi T Ito K Endo J Yamamoto T Takeshima A Shinmura K ShenW Fukuda K Sano M. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol 2013;62:24-35
25. Simon AM McWhorter AR. Decreased intercellular dye-Transfer and downregulation of non-Ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci 2003;116:2223-2236
26. Pfenniger A Derouette JP Verma V Lin X Foglia B Coombs W Roth I Satta N Dunoyer-Geindre S Sorgen P Taffet S Kwak BR Delmar M. Gap junction protein Cx37 interacts with endothelial nitric oxide synthase in endothelial cells. Arterioscler Thromb Vasc Biol 2010;30:827-834
27. Hasko G Linden J Cronstein B Pacher P. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008;7:759-770
28. Montesinos MC Takedachi M Thompson LF Wilder TF Fernandez P Cronstein BN. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: Findings in a study of ecto-5'-nucleotidase gene-deficient mice. Arthritis Rheum 2007;56:1440-1445
29. Garcia-Dorado D Inserte J Ruiz-Meana M Gonzalez MA Solares J Julia M Barrabes JA Soler-Soler J. Gap junction uncoupler heptanol prevents cell-To-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96:3579-3586
30. Rodriguez-Sinovas A Garcia-Dorado D Ruiz-Meana M Soler-Soler J. Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium. J Physiol 2004;559:245-257
31. Kanno S Kovacs A Yamada KA Saffitz JE. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 2003;41:681-686
32. Sanchez JA Rodriguez-Sinovas A Barba I Miro-Casas E Fernandez-Sanz C Ruiz-Meana M Alburquerque-Bejar JJ Garcia-Dorado D. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Basic Res Cardiol 2013;108: 351
33. Wang N De Vuyst E Ponsaerts R Boengler K Palacios-Prado NWauman J Lai CP De Bock M Decrock E Bol M Vinken M Rogiers V Tavernier J Evans WH Naus CC Bukauskas FF Sipido KR Heusch G Schulz R Bultynck G Leybaert L. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res Cardiol 2013;108:309
34. Fang JS Angelov SN Simon AM Burt JM. Compromised regulation of tissue perfusion and arteriogenesis limit in an AT1R-independent fashion recovery of ischemic tissue in Cx40(2/2) mice. Am J Physiol Heart Circ Physiol 2013;304:H816-H827
35. Mersmann J Latsch K Habeck K Zacharowski K. Measure for measure-determination of infarct size in murine models of myocardial ischemia and reperfusion: A systematic review. Shock 2011;35:449-455
36. Bolon ML Ouellette Y Li F Tyml K. Abrupt reoxygenation following hypoxia reduces electrical coupling between endothelial cells of wild-Type but not connexin40 null mice in oxidant- And PKA-dependent manner. FASEB J 2005;19:1725-1727
37. Rignault S Haefliger JAWaeber B Liaudet L Feihl F. Acute inflammation Decreases the expression of connexin 40 in mouse lung. Shock 2007;28:78-85
38. Kvietys PR Granger DN. Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med 2012;52:556-592
39. Toombs CF McGee S Johnston WE Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation During ischemia. Circulation 1992;86:986-994
40. Gerczuk PZ Kloner RA. An update on cardioprotection: A reviewof the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012;59: 969-978
41. McIntosh VJ Lasley RD. Adenosine receptor-mediated cardioprotection: Are all 4 subtypes required or redundant?. J Cardiovasc Pharmacol Ther 2012;17:21-33
42. Suissa S Bernatsky SHudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006;55:531-536
43. Westlake SL Colebatch AN Baird J Kiely P Quinn M Choy E Ostor AJ Edwards CJ. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review. Rheumatology (Oxford) 2010;49:295-307
44. Micha R Imamura F Wyler von Ballmoos M Solomon DH Hernan MA Ridker PM Mozaffarian D. Systematic review and meta-Analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol 2011;108:1362-1370
45. Asanuma H Sanada S Ogai A Minamino T Takashima S Asakura M Ogita H Shinozaki Y Mori H Node K Tomoike H Hori M Kitakaze M. Methotrexate and MX-68 a new derivative of methotrexate limit infarct size via adenosine-dependent mechanisms in canine hearts. J Cardiovasc Pharmacol 2004; 43:574-579
46. Rottlaender D Boengler K Wolny M Schwaiger A Motloch LJ Ovize M Schulz R Heusch G Hoppe UC. Glycogen synthase kinase 3b transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K+ channels. Proc Natl Acad Sci U S A 2012;109:E242-E251